Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.

被引:0
|
作者
Russo, Ricardo A. [1 ]
Katsicas, Maria M. [1 ]
机构
[1] Hosp Pediat, Buenos Aires, DF, Argentina
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S681 / S682
页数:2
相关论文
共 50 条
  • [31] DRAMATIC RESPONSE OF CACHEXIA TO ANTI-TNF THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS
    Harrison, K.
    McDonagh, J. E.
    RHEUMATOLOGY, 2014, 53 : 16 - 16
  • [32] Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
    Semeraro, Francesco
    Arcidiacono, Barbara
    Nascimbeni, Giuseppe
    Angi, Martina
    Parolini, Barbara
    Costagliola, Ciro
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 341 - 348
  • [33] Side effects of anti-TNF alpha therapy in juvenile idiopathic arthritis
    Pontikaki, Irene
    Gerloni, Valeria
    Gattinara, Maurizio
    Lurati, Alfredomaria
    Salmaso, Alessandra
    De Marco, Gabriele
    Teruzzi, Barbara
    Valcamonica, Elisabetta
    Fantini, Flavio
    REUMATISMO, 2006, 58 (01) : 31 - 38
  • [34] The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    Allez, M.
    Vermeire, S.
    Mozziconacci, N.
    Michetti, P.
    Laharie, D.
    Louis, E.
    Bigard, M. -A.
    Hebuterne, X.
    Treton, X.
    Kohn, A.
    Marteau, P.
    Cortot, A.
    Nichita, C.
    van Assche, G.
    Rutgeerts, P.
    Lemann, M.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) : 92 - 101
  • [35] Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis
    Tynjala, P.
    Lahdenne, P.
    Vahasalo, P.
    Kautiainen, H.
    Honkanen, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) : 1044 - 1049
  • [36] ABATACEPT AND ANTI-TNF MONOCLONAL ANTIBODIES: EFFICACY AND SAFETY COMPARISONS
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 461 - 462
  • [37] Abatacept and anti-TNF monoclonal antibodies: efficacy and safety comparisons
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 103 - 103
  • [38] Efficacy of the fully human anti-TNF antibody D2E7 in rheumatoid arthritis.
    van de Putte, BA
    Rau, R
    Breedveld, FC
    Kalden, JR
    Malaise, MG
    Schattenkirchner, M
    Emery, P
    Burmester, GR
    Zeidler, H
    Moutsopoulos, HH
    Compagnone, D
    Kempeni, J
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S400 - S400
  • [39] Efficacy of etanercept in the treatment of juvenile idiopathic arthritis
    de Inocencio Arocena, J.
    Merino Munoz, R.
    Alvarez Madrid, C.
    Garcia-Consuegra Molina, J.
    ANALES DE PEDIATRIA, 2009, 70 (04): : 354 - 361
  • [40] Safety and Efficacy of Etanercept in a Cohort of Patients with Juvenile Idiopathic Arthritis Under 4 Years of Age
    Bracaglia, Claudia
    Buonuomo, Paola S.
    Tozzi, Alberto E.
    Pardeo, Manuela
    Nicolai, Rebecca
    Campana, Andrea
    Insalaco, Antonella
    Cortis, Elisabetta
    De Benedetti, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (06) : 1287 - 1290